
Beyond Guinea Pigs: Patent Risks and Opportunities in AI-Enabled Drug Development
Introduction On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in drug development, signaling a major shift toward human-relevant, science-driven alternatives. This initiative …